Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -4.36%384.2M | -14.59%1.44B | -17.72%342.74M | -13.72%344.84M | -24.20%348.26M | -1.42%401.72M | 6.18%1.68B | -8.20%416.57M | 7.14%399.68M | 27.43%459.45M |
| Cost of revenue | -9.60%357.51M | -11.36%1.4B | -14.70%341.37M | -10.40%331.16M | -21.38%334.2M | 2.15%395.45M | 3.00%1.58B | -2.96%400.18M | 8.50%369.58M | 22.16%425.08M |
| Gross profit | 325.89%26.7M | -65.07%35.37M | -91.66%1.37M | -54.57%13.67M | -59.09%14.06M | -69.27%6.27M | 105.54%101.26M | -60.40%16.39M | -7.11%30.1M | 173.26%34.38M |
| Operating expense | 25.39%11.15M | 32.06%48.15M | 14.86%10.9M | 31.06%13.64M | 16.82%13.73M | 24.99%8.89M | -16.85%36.46M | -34.81%9.49M | 1.00%10.41M | 6.55%11.75M |
| Selling and administrative expenses | ---- | 23.22%53.24M | ---- | ---- | ---- | ---- | -12.44%43.21M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | -1.11%16.2M | ---- | ---- | ---- | ---- | 3.01%16.38M | ---- | ---- | ---- |
| -General and administrative expense | ---- | 38.08%37.05M | ---- | ---- | ---- | ---- | -19.78%26.83M | ---- | ---- | ---- |
| Other operating expenses | 4.96%12.5M | -7.08%801K | 17.79%13.31M | 18.99%13.64M | 5.22%13.94M | -2.45%11.91M | -74.53%862K | 134.34%11.3M | -13.01%11.46M | 8.12%13.25M |
| Total other operating income | -55.18%1.35M | -22.53%5.9M | 33.15%2.41M | ---- | -85.66%215K | -40.75%3.02M | -14.32%7.61M | -3.99%1.81M | -63.27%1.06M | 22.27%1.5M |
| Operating profit | 693.63%15.55M | -119.71%-12.78M | -238.32%-9.54M | -99.82%36K | -98.51%337K | -119.72%-2.62M | 1,096.44%64.8M | -74.29%6.9M | -10.90%19.69M | 1,356.99%22.63M |
| Net non-operating interest income (expenses) | 37.86%-4.33M | 1.41%-22.08M | 11.31%-5.18M | 30.67%-4.62M | -6.20%-5.33M | -42.51%-6.96M | -22.36%-22.39M | 3.25%-5.84M | -65.51%-6.66M | -25.47%-5.02M |
| Non-operating interest income | 15.43%531K | -7.53%2.03M | -13.65%487K | -25.37%453K | 20.81%627K | -8.37%460K | -7.63%2.19M | 1.81%564K | 30.82%607K | -19.41%519K |
| Non-operating interest expense | -34.56%4.86M | -1.95%24.1M | -11.52%5.66M | -30.23%5.07M | 7.57%5.95M | 37.76%7.42M | 18.92%24.58M | -2.82%6.4M | 61.93%7.26M | 19.24%5.53M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -14.72%35.8M | 79.07%138.39M | -36.71%30.22M | 8.34%40.85M | 200.39%25.34M | 352.81%41.98M | 73.61%77.28M | 178.62%47.75M | 2,680.84%37.71M | -69.36%8.43M |
| Special income (charges) | 143.07%991K | -97.17%-2.3M | ||||||||
| Less:Write off | ---- | -143.07%-991K | ---- | ---- | ---- | ---- | 97.17%2.3M | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 45.14%47.03M | -10.95%104.53M | -68.23%15.51M | -28.51%36.27M | -21.88%20.35M | 494.95%32.4M | 285.34%117.39M | 32.77%48.81M | 205.38%50.74M | 3.84%26.05M |
| Income tax | 235.49%3.37M | -157.57%-5.78M | -482.33%-4.44M | -55.73%1.55M | -109.51%-398K | -308.72%-2.49M | 834.33%10.03M | 121.99%1.16M | 221.84%3.49M | 106.77%4.19M |
| Net income | 25.13%43.66M | 2.74%110.31M | -58.14%19.94M | -26.50%34.73M | -5.10%20.74M | 471.33%34.89M | 237.29%107.36M | 13.35%47.65M | 204.23%47.25M | -5.20%21.86M |
| Net income continuous operations | 25.13%43.66M | 2.74%110.31M | -58.14%19.94M | -26.50%34.73M | -5.10%20.74M | 471.33%34.89M | 237.29%107.36M | 13.35%47.65M | 204.23%47.25M | -5.20%21.86M |
| Noncontrolling interests | -13.54%166K | 17.47%1.19M | 93.50%238K | 5.36%452K | -27.53%308K | 433.33%192K | 10.23%1.01M | 121.73%123K | -14.71%429K | -33.39%425K |
| Net income attributable to the company | 25.34%43.49M | 2.60%109.12M | -58.54%19.71M | -26.79%34.28M | -4.66%20.44M | 467.88%34.7M | 244.04%106.35M | 11.56%47.53M | 211.56%46.82M | -4.40%21.43M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 25.34%43.49M | 2.60%109.12M | -58.54%19.71M | -26.79%34.28M | -4.66%20.44M | 467.88%34.7M | 244.04%106.35M | 11.56%47.53M | 211.56%46.82M | -4.40%21.43M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 25.63%0.025 | 2.62%0.0626 | -58.61%0.0113 | -26.77%0.0197 | -4.88%0.0117 | 468.52%0.0199 | 244.63%0.061 | 11.89%0.0273 | 212.79%0.0269 | -4.65%0.0123 |
| Diluted earnings per share | 25.63%0.025 | 2.62%0.0626 | -58.61%0.0113 | -26.77%0.0197 | -4.88%0.0117 | 468.52%0.0199 | 244.63%0.061 | 11.89%0.0273 | 212.79%0.0269 | -4.65%0.0123 |
| Dividend per share | 0 | 0.00%0.005 | 0 | 0 | 0.00%0.005 | 0 | -50.00%0.005 | 0 | 0 | -50.00%0.005 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.